Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Infect Dev Ctries ; 14(6): 647-653, 2020 06 30.
Artigo em Inglês | MEDLINE | ID: mdl-32683356

RESUMO

INTRODUCTION: In this study, our aim was to prospectively compare the different methods of patient disinfections with scrubbing + iodine + alcohol, and the povidone iodine disinfection method, which can be described as classical, in terms of the pathogens isolated on skin and during early postoperative complications. METHODOLOGY: Eighty patients undergoing a coronary artery bypass operation were included in the study. The patients were divided into two groups: group 1 (n = 48) patients who underwent scrub, iodine, followed by skin disinfection with alcohol, and group 2 (n = 32) who were treated with povidone iodine three times. The samples were immediately sent to the microbiology laboratory. Specimens from the wounds were incubated under aerobic and anaerobic conditions, and isolates were identified using standard microbiological techniques. RESULTS: In samples taken after disinfection in group 1, significantly less reproduction was observed compared to group 2 (p = 0.001). There was no difference in postoperative complications between the two groups except for pleural effusion (p = 0.040). S. epidermidis was the most frequently isolated pathogen in both groups. CONCLUSION: We did not find a study which compares scrub + alcohol + iodine and povidone iodine in our literature review. We think that our study is original in this respect. We can conclude that skin disinfection with scrub + alcohol + iodine was superior to using only povidone iodine in terms of the pathogens isolated afterwards from the wound.


Assuntos
Anti-Infecciosos Locais/farmacologia , Bactérias/efeitos dos fármacos , Procedimentos Cirúrgicos Cardíacos/normas , Desinfecção/métodos , Desinfecção/normas , Cuidados Pré-Operatórios/métodos , Cuidados Pré-Operatórios/normas , Idoso , Bactérias/isolamento & purificação , Bactérias/patogenicidade , Clorexidina/farmacologia , Etanol/farmacologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Povidona-Iodo/farmacologia , Estudos Prospectivos , Pele/efeitos dos fármacos , Pele/microbiologia , Infecção da Ferida Cirúrgica/microbiologia , Infecção da Ferida Cirúrgica/prevenção & controle
2.
Eur J Clin Microbiol Infect Dis ; 39(1): 45-52, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31502120

RESUMO

Ventilator-associated pneumonia (VAP) due to Acinetobacter spp. is one of the most common infections in the intensive care unit. Hence, we performed this prospective-observational multicenter study, and described the course and outcome of the disease. This study was performed in 24 centers between January 06, 2014, and December 02, 2016. The patients were evaluated at time of pneumonia diagnosis, when culture results were available, and at 72 h, at the 7th day, and finally at the 28th day of follow-up. Patients with coexistent infections were excluded and only those with a first VAP episode were enrolled. Logistic regression analysis was performed. A total of 177 patients were included; empiric antimicrobial therapy was appropriate (when the patient received at least one antibiotic that the infecting strain was ultimately shown to be susceptible) in only 69 (39%) patients. During the 28-day period, antibiotics were modified for side effects in 27 (15.2%) patients and renal dose adjustment was made in 38 (21.5%). Ultimately, 89 (50.3%) patients died. Predictors of mortality were creatinine level (OR, 1.84 (95% CI 1.279-2.657); p = 0.001), fever (OR, 0.663 (95% CI 0.454-0.967); p = 0.033), malignancy (OR, 7.095 (95% CI 2.142-23.500); p = 0.001), congestive heart failure (OR, 2.341 (95% CI 1.046-5.239); p = 0.038), appropriate empiric antimicrobial treatment (OR, 0.445 (95% CI 0.216-0.914); p = 0.027), and surgery in the last month (OR, 0.137 (95% CI 0.037-0.499); p = 0.003). Appropriate empiric antimicrobial treatment in VAP due to Acinetobacter spp. was associated with survival while renal injury and comorbid conditions increased mortality. Hence, early diagnosis and appropriate antibiotic therapy remain crucial to improve outcomes.


Assuntos
Infecções por Acinetobacter/tratamento farmacológico , Antibacterianos/uso terapêutico , Pneumonia Associada à Ventilação Mecânica/tratamento farmacológico , Pneumonia Associada à Ventilação Mecânica/microbiologia , Acinetobacter/efeitos dos fármacos , Acinetobacter/patogenicidade , Idoso , Feminino , Humanos , Unidades de Terapia Intensiva , Pulmão/microbiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco
3.
Exp Clin Transplant ; 12(1): 71-3, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23742155

RESUMO

Coccidioidomycosis is a fungal infection caused by the Coccidioides species, endemic to the southwestern United States. In healthy people, manifestations range mainly from asymptomatic to mild influenza-like signs, whereas in immunosuppressed patients (eg, transplant recipients) this infection is often a severe disseminated disease. We report a case of primary pulmonary coccidioidomycosis in a 61-year-old man with a renal transplant 7 months earlier. The patient had nonspecific symptoms of pulmonary infection, including weakness, anorexia, and weight loss. Both spherules and endospores of Coccidioides immitis were seen histologically after a transbronchial biopsy of a cavitary lesion. The patient was treated with amphotericin B. At the time of this writing (8 months), he remains disease free.


Assuntos
Coccidioides/isolamento & purificação , Coccidioidomicose/microbiologia , Transplante de Rim/efeitos adversos , Pneumopatias Fúngicas/microbiologia , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Biópsia , Coccidioidomicose/diagnóstico , Coccidioidomicose/tratamento farmacológico , Humanos , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Turquia
4.
Heart Surg Forum ; 16(5): E276-8, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24364083

RESUMO

We report the case of a 75-year-old male patient who was treated in our clinic for septicemia and subacute infective endocarditis caused by toxigenic Candida albicans. Transthoracic echocardiography revealed the presence of a thrombus in the left atrial cavity, and the diagnosis was confirmed by computerized tomography. The patient was operated on urgently. Histological examination of the embolic material removed from the left atrium showed the presence of yeast and hyphal forms of Candida albicans through periodic acid-Shiff stain. The patient was readmitted to the hospital on postoperative day 15, because of reembolism, and died later on. Here we present our approach to the diagnosis and treatment of this rare condition.


Assuntos
Candidíase/diagnóstico , Candidíase/cirurgia , Endocardite/diagnóstico , Endocardite/cirurgia , Infarto do Miocárdio/diagnóstico , Infarto do Miocárdio/cirurgia , Idoso , Candidíase/microbiologia , Diagnóstico Diferencial , Endocardite/microbiologia , Átrios do Coração/microbiologia , Átrios do Coração/cirurgia , Humanos , Masculino , Infarto do Miocárdio/microbiologia , Doenças Raras/diagnóstico , Doenças Raras/microbiologia , Doenças Raras/cirurgia
5.
Braz. j. infect. dis ; 13(6): 403-407, Dec. 2009. tab
Artigo em Inglês | LILACS | ID: lil-546007

RESUMO

This prospective case-control study was conducted from October 2003 to June 2007 to evaluate risk factors for multidrug resistance among extended-spectrum-b-lactamase-producing Escherichia coli and Klebsiella spp. (ESBL-EK) isolates in blood cultures. All adult patients (>18 years old) whose blood cultures grew ESBL-EK during the study period were included. An ESBL-EK isolate was defined as MDR if it was resistant to at least one member of following two classes of antibiotics: aminoglycosides (amikacin, gentamicin, or netilmycin) and fluoroquinolones (ofloxacin, or ciprofloxacin). Case patients were those with a MDR ESBL-EK isolate, and control patients were those with a non-MDR ESBL-EK isolate. A total of 94 bloodstream infections, including 37 (39,4 percent) bloodstream infections with ESBL-producing E. coli and 57 (60,6 percent) with ESBL-producing K. pneumoniae,in 86 patients were enrolled. Thirty episodes (31.9 percent) were due to MDR ESBL-EK. The only independent risk factor for MDR ESBL-EK was duration of hospitalization before bacteraemia (OR 3.88; 95 percent CI 1.55-9.71; p=0.004). The rate of multidrug resistance among ESBL-EK bloodstream isolates was high, and duration of hospitalization before bacteraemia was the only indeepended risk factor for the MDR ESBL-EK bloodstream infections.


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Farmacorresistência Bacteriana Múltipla , Escherichia coli/efeitos dos fármacos , Fluoroquinolonas/farmacologia , Klebsiella pneumoniae/efeitos dos fármacos , Bacteriemia/microbiologia , Estudos de Casos e Controles , Infecção Hospitalar/microbiologia , Infecções por Escherichia coli/microbiologia , Escherichia coli/enzimologia , Infecções por Klebsiella/microbiologia , Klebsiella pneumoniae/enzimologia , Testes de Sensibilidade Microbiana , Estudos Prospectivos , Fatores de Risco , beta-Lactamases/biossíntese
6.
Braz. j. infect. dis ; 13(4): 249-251, Aug. 2009. tab
Artigo em Inglês | LILACS | ID: lil-539757

RESUMO

Oxidative stress can be defined as an increase in oxidants and/or a decrease in antioxidant capacity. We aimed to determine total antioxidant capacity (TAC), total peroxide, malondialdehyde and catalase levels in plasma samples, and calculation of oxidative stress index (OSI) in patients with brucellosis to evaluate their oxidative status using a novel automated method. Sixty-nine patients with brucellosis and 69 healthy control subjects were included in the present study. Plasma levels of total peroxide and malondialdehyde were significantly increased in patients as compared with healthy controls (p<0.001 and p<0.001, respectively). In contrast, TAC level was significantly lower in patients as compared with controls (p<0.001). There was no statistically significant difference between the catalase results of the two groups (p>0.05). OSI level was significantly increased in patients as compared with healthy controls (p<0.001). In conclusion, oxidants were increased and antioxidants were decreased in patients with brucellosis. Oxidative stress was increased in patients with brucellosis.


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Brucelose/metabolismo , Estresse Oxidativo/fisiologia , Antioxidantes/análise , Biomarcadores/sangue , Brucelose/sangue , Estudos de Casos e Controles , Catalase/sangue , Malondialdeído/sangue , Peróxidos/sangue
8.
Eur Arch Otorhinolaryngol ; 265(7): 775-80, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18043932

RESUMO

The goal of this study was to investigate clinical characteristics of chronic rhinosinusitis (CRS) in patients with positive fungal cultures. Fungal cultures were taken from 55 CRS patients and 20 healthy volunteers. Susceptibilities of isolated fungi to fluconazole, amphotericin B, itraconazole, voriconazole, and caspofungin were determined in CRS patients. Fungi grew in the cultures from 44 (80%) CRS patients and 17 (85%) healthy volunteers. Of the patients with positive fungal cultures, 5 (11.3%) had fungal hypersensitivity (FH), and 21 (47.7%) had eosinophilic mucin (EM). Fungal culture-positive patients with EM were more likely to be associated with presence of polyps and higher CT scores than those without EM (P < 0.05). All the patients with FH had EM and polyps, and CT scores of those patients were highest. The sensitivity rates of fungal isolates were 97.8% for amphotericin B, caspofungin, and voriconazole; 74.4% for itraconazole; and 6.4% for fluconazole. The presence of EM with or without FH leaded to more extended CRS, but a part of positive fungal cultures were together with EM in patients with CRS. Sensitivity to antifungal agents, except fluconazole, was high. Because many factors can contribute to the pathogenesis of CRS, medical treatment should be considered on a case-by-case basis.


Assuntos
Antifúngicos/uso terapêutico , Infecções Bacterianas/complicações , Infecções Bacterianas/epidemiologia , Fungos/isolamento & purificação , Fungos/patogenicidade , Rinite/epidemiologia , Rinite/microbiologia , Sinusite/epidemiologia , Sinusite/microbiologia , Adulto , Idoso , Infecções Bacterianas/tratamento farmacológico , Doença Crônica , Suscetibilidade a Doenças , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Rinite/tratamento farmacológico , Sinusite/tratamento farmacológico
9.
Int J Urol ; 13(1): 25-8, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16448428

RESUMO

AIM: The assumed necessity of antimicrobial prophylaxis prior to cystoscopy is controversial. In this study, the rate of bacteriuria, pyuria and bacteremia in outpatients who underwent cystoscopy without antimicrobial prophylaxis is investigated prospectively. METHODS: The study included 75 patients who underwent cystoscopy for various indications and had sterile urine prior to intervention. A clean midstream urine sample was obtained 24 h before and 48 h after the procedure. Blood cultures were taken 1 h after cystoscopy. Patients were questioned for newly developed symptoms 48 h after cystoscopy. Blood cultures were taken again from patients who presented with fever. RESULTS: Six patients (8%) developed significant bacteriuria, and six patients (8%) developed pyuria without significant bacteriuria. Bacteremia was not determined in any of the patients. The association between presence of pyuria prior to the procedure and development of bacteriuria after the procedure was significant (P < 0.05). Four patients out of six who had bacteriuria were asymptomatic. In our study we found significant bacteriuria after cystoscopy in 8% of patients, and no bacteremia. CONCLUSIONS: Thus we conclude that cystoscopy is a safe and well-tolerated procedure. Antimicrobial prophylaxis should not be administrated unless specific indications are present.


Assuntos
Procedimentos Cirúrgicos Ambulatórios/efeitos adversos , Bacteriemia/epidemiologia , Bacteriúria/epidemiologia , Cistoscopia/efeitos adversos , Piúria/epidemiologia , Adolescente , Adulto , Idoso , Bacteriemia/etiologia , Bacteriúria/etiologia , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Piúria/etiologia , Fatores de Risco
10.
J Natl Med Assoc ; 97(3): 418-20, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15779510

RESUMO

A 65-year-old man underwent coronary artery bypass graft surgery at our tertiary care hospital. Perioperatively, he was transfused with four units of nonirradiated whole blood from first-degree relatives and discharged from the hospital at postoperative day seven. He presented six days later with fever, skin rash, elevated liver enzymes, and progressive pancytopenia. Elevated bilirubin levels and diarrhea were added to the clinical picture over the following days. Clinical findings and results of a skin biopsy specimen were consistent with transfusion-associated graft-versus-host disease. The patient died 20 days after transfusion.


Assuntos
Ponte de Artéria Coronária , Doença Enxerto-Hospedeiro/etiologia , Reação Transfusional , Idoso , Evolução Fatal , Humanos , Imunocompetência , Cuidados Intraoperatórios , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA